Bovie Medical Corporation (the “Company”) (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, today announced that it has employed Mr. Leonard Keen, Esq. as Vice President and General Counsel, effective March 2, 2010. Mr. Keen is responsible for managing the Company’s legal and strategic affairs, and working as a member of the executive management team to strengthen operations for growth and competitiveness.
“We are pleased that Mr. Keen has joined Bovie at this time. He is multi-skilled and will be involved in areas of the Company’s business development requiring his legal and technical advice,” stated Andrew Makrides, President and Chief Executive Officer of Bovie Medical.
Prior to joining the Company, Mr. Keen has worked as an attorney, business executive, entrepreneur and technologist. He served as a partner with Kaplan, Ward & Patel, an associate with Allen Dyer Doppelt Milbrath & Gilchrist and a solo practitioner where he specialized in intellectual property and business law. He also served as Vice President of Legal and Strategic Affairs at Kinetics, Inc. (a NCR Subsidiary) and as Chief Information Officer at Payroll Transfers, Inc.
Mr. Keen received a Bachelor of Science degree in Chemistry/Mathematics from the University of Miami and a Juris Doctor, with honors, from the University of Florida Levin College of Law. In addition to being a U.S. registered patent attorney and member of the Florida Bar, Mr. Keen has extensive experience in the technical, business and executive management fields.An employment agreement with Mr. Keen was entered into on March 2, 2010, and as part thereof, he was awarded a restricted non-qualified stock option for an aggregate of 100,000 shares of common stock, exercisable at the closing price on that date. The option has a ten year term and vests over seven years, or at the rate of 14.29 percent per annum. This press release is issued in accordance with the exemption afforded under Section 711(a) of the NYSE AMEX Company Guide which exempts certain stock option grants made as an inducement to employment from the stockholder approval requirement.